Both Semaglutide and Mounjaro represent groundbreaking approaches to addressing type 2 diabetes, and increasingly, obesity. It is a dual agonist that targets multiple hormones involved in metabolism: this peptide and GIP. It, often considered as a product name for Tirzepatide, functions similarly… Read More